Posted by Michael Wonder on 19 Apr 2017
Reevaluating eligibility criteria — balancing patient protection and participation in oncology trials
19 April 2017 - Specific patient populations are often excluded from oncology trials without clear reasons, which renders results less clearly applicable to all patients.
A more logical approach would be to study safety in a broad population and modify criteria as knowledge emerges.
